Skip to content
  • Saturday, May 17, 2025

New Economy World

The world economy is the economy of all humans in the world

Banner Add
  • Home
  • Blog
  • Finance News
  • Insurance
  • Investing
  • Construction
  • Property
  • Stock
  • Tech
  • Venture Capital
  • Home
  • Stock
  • 8×8 Inc: Sylebra Capital sells shares worth $226,741
Stock

8×8 Inc: Sylebra Capital sells shares worth $226,741

26/03/2025
admin


8×8 Inc: Sylebra Capital sells shares worth $226,741#8×8 #Sylebra #Capital #sells #shares #worth

Tags: 8x8, Capital, sells, shares, Sylebra, worth

Post navigation

Verisk Analytics: Solid Growth Outlook Convinced Me To Upgrade To A Buy
Templeton Sustainable Emerging Markets Bond Fund Q4 2024 Commentary

Finance and Economics

Recent Posts

Finance News

Pet Valu: Benefiting From Buy Canada Movement

17/05/2025
admin
Stock

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure

17/05/2025
admin
Tech

Y Combinator startup Firecrawl is ready to pay $1M to hire three AI agents as employees

17/05/2025
admin
Finance News

Total Return Breakouts: Highest Positive Signal Of The Year Fuels Short Squeeze And FOMO

17/05/2025
admin
Stock

Republicans spike Trump tax bill over spending worries, Moody's cuts US rating

17/05/2025
admin
Finance News

Billion-Dollar Shift: Embedded Finance for Business

17/05/2025
admin
Stock

Italy's Tajani tells Israel to halt Gaza offensive

17/05/2025
admin

Recent Posts

Finance News

Pet Valu: Benefiting From Buy Canada Movement

17/05/2025
admin
Stock

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure

17/05/2025
admin

Recent Posts

Finance News

Pet Valu: Benefiting From Buy Canada Movement

17/05/2025
admin
Stock

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure

17/05/2025
admin

Recent Posts

Finance News

Pet Valu: Benefiting From Buy Canada Movement

17/05/2025
admin
Stock

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure

17/05/2025
admin
New Economy World News